The ideal setting for this approach is a special unit in which appropriate skills can be practised and taught. Some large hospital centres have established toenail clinics calling on the interrelated specialties and catering for many patients. Yet a group practice may be the best place to site a toenail clinic: costs are generally lower, and many surgeries and health centres provide a setting for close liaison with other disciplines such as district nurses and chiropody services. The patient receives his treatment sooner from the general practitioner at the time of first presentation with a shorter waiting time. Referral to hospital invariably causes delay, and the hospital visit can be a forbidding experience.
Well tested techniques can be learnt and applied by the general practitioner. Treatment has to be tailored to two main groups of patients. When the patient presents with an acutely infected ingrowing toenail simple conservative measures are very unlikely to produce a prompt response and control of infection. Avulsion of the nail is more likely to achieve this, but removal of the whole nail is not necessary; a sliver of the nail edge may be taken off, as suggested by Fowler,' and this can be done without local anaesthetic with minimal discomfort to the patient.2 Another approach with equally reliable results is the gutter technique, carefully assessed and described by Wallace et al. 3 In the case of the recurrent or chronic ingrowing toenail some form of ablation of the germinal matrix is needed, and there seems very little to choose between segmental excision4 and phenol ablation' in terms of results.
The choice of technique should be left to individual preference. Neither is "easier" and both require close attention to detail, not only of operative techniques but also of postoperative dressings and careful follow up in the short and long term.
Total nail bed ablation should be reserved for the uncommon case where the whole nail is embedded and in onychogryphosis.
S 
Treating hay fever
An increased understanding of the pathophysiology of pollenosis (see leading article last week, p 1) enables treatment to be based on rational grounds. H, antihistamines have long been known to be an effective treatment of hay fever. Two new antihistamines, terfenadine and astemizole, have recently become available which are free of the sedative and anticholinergic side effects associated with the older preparations.'2 Though both of these drugs are potent H, receptor antagonists, they differ in their pharmacokinetics. Terfenadine has a rapid onset and offset of action and is therefore ideally suited for intermittent symptomatic treatment. If it is to be used prophylactically then 60 mg twice daily is recommended.3 By contrast, astemizole has a slower onset of action and a prolonged half life of up to 19 days on account of its slow release from hepatic lysozomes and its almost irreversible binding to H, receptors.4 Though the delayed onset of maximal action of astemizole may be overcome to some extent by giving a loading dose, this drug is better for maintenance than occasional use.
Many patients gain considerable benefit from the use of H, antagonists, but their main effects are on sneezing, rhinorrhoea, and conjunctivitis with little impact on nasal obstruction. Should this latter symptom present a problem then the additional use of an inhaled steroid should be considered.6 It is likely that the anti-inflammatory effect of nasal steroids is manifested through their inhibitory activity on the colonisation of the mucosa with mast cells,7 the generation of newly formed mediators,8 and inhibition of leucocyte chemotaxis, thereby limiting the inflammatory cell component of the disease.9 Mast cell stabilising drugs such as sodium cromoglycate, ketotifen, and nedocromil may also be helpful as prophylactic agents, but since these drugs have minimal effects on basophil degranulation they provide only partial relief of symptoms.'0 Immunotherapy with specific and purified allergen extracts is widely advocated in the prophylactic treatment of hay fever, but frequent injections are required for effective results and there is an appreciable morbidity unless they are given in controlled conditions where anaphylactic reactions may be treated swiftly." To overcome these systemic effects, local nasal immunotherapy has been tried. This has been successful with moderate doses of aqueous allergen extract'2 but is associated with appreciable local adverse reactions. Reduction of the allergen dose to minimise the local adverse effects has unfortunately not been found to be clinically beneficial in preventing seasonal allergic nasal symptoms." Pollenosis affects 10-15% of the population, and, though its symptoms may often be relatively mild and temporary, they deserve the benefit ofoptimal treatment since they occur in summer, when examinations and outside recreational activities dominate.
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